Executive team

Dr Gordon Sanghera

Gordon Sanghera is co-founder of Oxford Nanopore with Spike Willcocks and Hagan Bayley. He was appointed CEO in May 2005 and has led the company through multiple finance rounds, and in 2021, a listing on the London Stock Exchange. The company has developed a new generation of nanopore-based sensing technology. The first products enable the real-time, high-performance, accessible and scalable analysis of DNA and RNA, and this new class of sensing has the potential to expand into proteomics and metabolomics.

Fully bespoke manufacturing capability has been built from the ground up, integrating state of the art electronics with silicon fab technology combining the chemistry and biology. The company has been commercially distributing sequencing platforms since 2015, including the handheld and portable MinION and Flongle, and the high-throughput benchtop devices, GridION and PromethION. These platforms are used in more than 100 countries to understand the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses and whole environments.

Dr Sanghera’s PhD in bioelectronic technology was followed by a career at MediSense — an Oxford spin-out that delivered a new generation glucose technology to the market — where he held positions including VP World Wide Marketing, Research Director and Manufacturing Process Development Director. During this time, he was instrumental in the launch of several generations of blood glucose bio-electronic systems for the consumer and hospital medical markets.

Nick Keher

Nick is an experienced life sciences CFO, having previously served as CFO of Clinigen Group and Benevolent AI. Prior to his CFO roles he gained extensive experience in the life sciences industry serving as Managing Director and Head of the European healthcare equity research team at Royal Bank of Canada (RBC) and before that held roles at Investec and GSK after switching from practising pharmacy. Nick comes to the role with significant experience of financial leadership of complex, scientific businesses, and has a deep understanding of capital markets. Nick has responsibility for the Group’s finance function and investor relations.

Dr Spike Willcocks

After studying Chemistry at the University of Oxford and completing a DPhil in Biochemistry, Spike started working for the intellectual property investment business “IP Group” in 2001 as an early employee.

He ultimately led its Life Sciences group, and was responsible for the formation of Oxford Nanopore Technologies during that time. Gordon persuaded Spike to join Oxford Nanopore full time at the start of 2006, leading the Corporate and Business development function, and now he is the company’s Chief Strategy Officer.

Clive Brown

Clive Brown is Chief Technology, Innovation and Product Officer of Oxford Nanopore, where he leads the innovation of breakthrough technologies and product development, that are designed to enable the analysis of anything, by anyone, anywhere.

Clive has held a variety of roles in Genomics and Genetic R&D, he also played a key role in developing the Solexa NGS platform that is now the basis for Illumina’s sequencing technology.

John Schoellerman

John joined Oxford Nanopore in 2019 as SVP of Corporate Development and Investor Relations.

Together with the executive leadership team, John works on a range of fundraising and partnering activities aimed at scaling the business and tapping new growth opportunities for Oxford Nanopore’s technology.

Previously a Managing Director and head of the Medtech practice at Lazard, John led a broad range of strategic transactions for clients in the US, Europe and Asia. He has also worked in healthcare investment banking at J.P. Morgan in San Francisco, London and New York. John started his career at Hambrecht & Quist in San Francisco. John holds a BA from Harvard and an MBA from INSEAD.

Tim Cowper

A Chartered Accountant and operations specialist, Tim was interim Finance Director at Oxford Nanopore for several months in 2009, handing over a stable and well documented finance infrastructure. He then joined Oxford Nanopore as Commercial Operations Director in 2012.

In his first five years at the company Tim was responsible for setting up and managing operations and infrastructure across the company, including leading on operations for our first product launch – the MinION Access Programme – in 2015.

As part of his Operations role, Tim selected and implemented our Enterprise Resource Planning system which has remained robust and fit for purpose throughout the company's rapid growth and development.

Tim was appointed as VP-Finance in 2017 and continues to ensure that Oxford Nanopore’s values of agility and entrepreneurialism are reflected in our corporate governance, risk control and business processes, to maximise business efficiency.

Having qualified as an accountant at Ernst & Young, Tim became Financial Controller of Celltech Group plc where he was a key member of the IPO team and managed several transactions of the Listed company. He went on to co-found Sterilox and ran the finance function before joining Clipper Ventures plc as Finance Director. Tim has also been Finance Director at British Biotech plc (Vernalis plc) as well as managing a portfolio of biotech and technology companies, including the AIM-listed Bioventix plc, before joining Oxford Nanopore.

Zoe McDougall

Zoe joined Oxford Nanopore in 2008 in a strategic marketing, communications and investor facing role - the first person to be hired with a specific external remit. She now leads the Company’s Corporate Affairs function, as Oxford Nanopore expands to engage with broader stakeholders, from scientific researchers to governments and policymakers.

Since the foundation of the company she has driven accessible and authentic communities, communication channels and marketing processes and teams so that anyone engaging with, or interested in, Oxford Nanopore understands the company, our technology and our philosophy. During early commercialisation, Zoe and her team drove the creation of structures and activities that enabled the building up of Oxford Nanopore’s customer community; this enables many teams at Oxford Nanopore to collaborate with our thriving user base, to improve the technology and expand the applications that it can perform. She subsequently built Marketing functions and was part of the Company’s IPO team.

Sarah Lapworth

Sarah is the VP of Global Human Resources at ONT. She started consulting for ONT in 2011 before joining full time in 2013 as our first HR hire. Her initial remit was to support the executive team on critical long-term leadership recruitment, culture creation and infrastructure development around policy, process, and communication.

From day one, Sarah’s objective has been to recruit, retain and develop the best person for each role, wherever they are in the world. To this end, Sarah was instrumental in collaborating with our executive team to develop a culture imbued with our core values. Since then, we have embedded collaboration, fostered flexible working, and continue to prioritise physical and mental health, wellbeing, healthy communication and respect, all within a reward ethos.

ONT teams around the world represent a diverse and inclusive variety of people, all empowered to be responsible for their own time and delivery thanks to technology, a coaching framework, training, and accessible resources.

Alongside continually embedding our culture, talent acquisition and development, Sarah and her team have developed policies and processes which have supported ONT’s strategic transition. Once an early-stage R and D start up, ONT is now a global commercial business with the vision and technology to impact everyone and everything.

Since she completed her Business Apprenticeship in 1996, Sarah’s had national and global roles in the automotive, medical device and biotech industries, including playing an instrumental role in designing and implementing ADC’s transformation programme.

Sarah is a Chartered Member of the CIPD and holds a BA Honours Degree in Business Studies and Human Resource Management and a Post Graduate Diploma in Human Resource Management.

Jordan Herman

Jordan Herman joined Oxford Nanopore in 2021 as General Counsel. Prior to this Jordan was a partner at Baker Botts L.L.P., where he was our outside counsel for over a decade. He’s long been involved in supporting our growth from a dozen people to a global company; from an idea to an industry leading technology.

Jordan leads our growing in-house legal team, and his responsibilities reflect our growth journey both corporately and commercially. His main remit is to ensure his team have the desire and ability to enable the company to grow, flourish and innovate while remaining legal, ethical and reflecting our values.

Jordon’s role includes supporting and collaborating with leadership team, overseeing the legal department, negotiating legal transactions and identifying and managing risk. He and his team are also working on strengthening internal controls, simplifying our terms and conditions and establishing processes for global monitoring and compliance.

Jordan has many years’ experience in areas including technology transfer and commercial agreements, M&A, joint ventures, licensing, and venture capital. He has worked across the life science, software, medical device and digital media industries, supporting high growth businesses in the US, Europe and around the world.

Jordan was most recently Baker Botts L.L.P., Chair of the Austin Office Corporate Department and Co-Chair of the Life Sciences group. He JD from The Ohio State University, following which he clerked for the Hon. James Rosenbaum, formerly, Chief Judge for the U.S. District Court, District of Minnesota. Jordan also has a degree in Political Economy from Washington University.

Rosemary Sinclair Dokos MBA

Rosemary Sinclair Dokos, Chief Product & Marketing Officer, joined Oxford Nanopore in January 2014. Her initial role included the implementation of product management, release and distribution framework around the MinION Access Programme.

Rosemary is responsible for the management and release of all Oxford Nanopore devices, chemistry and software products. Part of this role is to ensure that teams across R&D, production, commercial and operations work together to accelerate innovation from our research teams into the hands of the customer and scale our offering to our growing user base.

Rosemary has over 15 years’ experience in the life science industry. Prior to joining Oxford Nanopore, she led the Market Development and Life Science division of VWR UK where she was responsible for teams in technical sales, field marketing and contracts. In this role she worked with customers across all scientific industry sectors and managed a portfolio of over 600,000 products. Rosemary holds a BSc in Marine Sciences from the University of Southampton and is currently undertaking an executive MBA at Warwick Business School.

Rosemary and her team maintain a close connection with our user community, ensuring their experiences of using Oxford Nanopore devices inform our product development cycle.

Dr. Lakmal Jayasinghe

As the Chief Scientific Officer, Dr. Lakmal Jayasinghe oversees all biological research and development projects at Oxford Nanopore. Lakmal joined ONT in 2006 after finishing his PhD in chemical biology in the University of Oxford. During his PhD in the Hagan Bayley group, Lakmal has studied different nanopores and has gained a wealth of knowledge in engineering nanopores using genetic and chemical approaches. His responsibilities at Oxford Nanopore include improving the readout signal and performance of Oxford Nanopore platforms by upgrading its current nanopore reader and motor, as well as discovering new versions of nanopores, motors and chemistries to suit various Oxford Nanopore applications including protein sequencing.

Lakmal also works with many academic collaborators across the world to ensure that Oxford Nanopore uses the best possible biological components and chemistries in its platforms.

Kathleen Barnes

Kathleen’s career spans >30 years focused on genomic medicine and precision-driven health equity. She completed her BSN at the Medical College of Virginia, her PhD in Biomedical Anthropology at the University of Florida, and a postdoctoral fellowship in Immunogenetics at Johns Hopkins University.

She has built research and clinical programs and has led interdisciplinary teams integrating biomedical informatics, multi-omics platforms, translational research and global health at Johns Hopkins University (1993-2015) and the University of Colorado (2015-present), where she founded the Colorado Center for Personalized Medicine, and was SVP of Population Genomics Health at Tempus Labs (2021-2023).

Richard Compton

Richard joined Oxford Nanopore in 2016 to help build our commercial team from scratch. He is now responsible for the leadership of commercial operations units including global IT, business systems, digital services, global commercial operations, technical and customer services.

His remit includes key Customer Relationship Management including leading support of the Abu Dhabi Genome Programme; the world-leading population-scale initiative to develop personalised care and personalised medicine for the region.

Richard also ensures our commercial systems, processes and teams are ready to scale and support our continued growth – drawing on experience from leading Illumina’s EMEA Region, as Vice President and General Manager, prior to joining Oxford Nanopore.

At Illumina, Richard led a team of over 300 people and grew revenues by over $300m across a three-year timeframe. He also led the support of multiple population-scale sequencing programmes including Genomics England and deCODE genetics.

Richard also brings 12 years of experience as SVP and General Manager (EMEA) of Dassault Systèmes Biovia. In this role he helped commercial and research customers successfully integrate and deploy enterprise scale software solutions in research and quality/regulated environments.

Richard holds a degree in Biochemistry with Cell and Molecular Biology from the University of Birmingham.

Oxford Nanopore Technologies Logo

PRODUCTS

APPLICATIONS STORE RESOURCES SUPPORT

ABOUT

Contact Login / Register WHICH AREA OF CONTENT WOULD YOU LIKE TO SEARCH? ALL What would you like to search for?

HOME/ABOUT US/ Executive team About Oxford Nanopore About us Executive team Board members For partners Company history Media resources Sustainability EXECUTIVE TEAM DEPARTMENTAL LEADERS Executive team The Oxford Nanopore executive team has combined experience in the development, manufacture and commercialisation of disruptive technologies including DNA sequencing. This includes a corporate function to support the Company's past and future fundraising activities.

Dr Gordon Sanghera CHIEF EXECUTIVE OFFICER Nick Keher CHIEF FINANCIAL OFFICER Dr Spike Willcocks CHIEF STRATEGY OFFICER Clive Brown CHIEF TECHNOLOGY, INNOVATION AND PRODUCT OFFICER John Schoellerman SVP, CORP & BUS DEV Tim Cowper CHIEF OPERATING OFFICER Zoe McDougall GLOBAL HEAD, SVP, CORPORATE AFFAIRS Sarah Lapworth SVP, GLOBAL HUMAN RESOURCES Jordan Herman SVP, GENERAL COUNSEL

Departmental leaders Rosemary Sinclair Dokos MBA SVP, PRODUCT & PROGRAMME MANAGEMENT Emma Stanton SVP, CLINICAL AND HEAD OF OND Roger Pettett VP, INFORMATICS Lakmal Jayasinghe SVP, R&D BIOLOGICS Dr James Clarke VP, PLATFORM TECHNOLOGY Kathleen Barnes SVP POPULATION HEALTH & PRECISION MEDICINE Stuart Reid VP, DEVELOPMENT Ant Jones VP, ENGINEERING Andy Davies VP, GLOBAL IT & CUSTOMER SOLUTIONS Nirmala Santiapillai VP, COMMERCIAL OPERATIONS Louisa Ludbrook VP, COMMERCIAL MARKET DEVELOPMENT Richard Compton SVP, SALES AND COMMERCIAL OPERATIONS Martyn Andrews VP, INTELLECTUAL PROPERTY Phil Watkins VP, FINANCE Rhodri Davies VP, OPERATIONS Jeremy Bryar VP, MANUFACTURING Alvaro Correia VP, GLOBAL SUPPLY CHAIN Sara Agee Le VP OF GLOBAL MARKETING Hannah Coote SENIOR DIRECTOR, ASSOCIATE GENERAL COUNSEL Chris Brown VP, STRATEGIC PROGRAMMES Kristen Stoops VP, BUSINESS DEVELOPMENT Howard Orman VP, TECH TRANSFER, QUALITY & REGULATORY

中文 日本語 English GETTING STARTED Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners Japanese dealers NANOPORE TECHNOLOGY Subscribe to Nanopore updates Resources and publications What is the Nanopore Community ABOUT OXFORD NANOPORE News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information CONTACT US Oxford, UK Harwell, UK New York (NY), USA Lexington (MA), USA San Francisco (CA), USA Shanghai, China Tokyo, Japan Singapore, Singapore Oxford Nanopore Technologies

Oxford Nanopore Technologies ISO 27001 Oxford Nanopore TechnologiesISO 9001 Oxford Nanopore Technologies BSI Mark of trust Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility © 2008 - 2024 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.

Roger Pettett

Roger is responsible for all Informatics and IT provision at Oxford Nanopore. He started at Oxford Nanopore in the mists of time with a background in scalable web systems and NGS data management from 10 years spent at the Hinxton Genome Campus. Roger has at least one line of code in nearly every piece of software ever produced at Nanopore. Roger literally and figuratively wears hats of many different colours but routinely spends most of his waking hours converting coffee into code.

Likes good software engineering practices, reading and walks in the park. Roger is easily distracted by shiny things and would rather be making stuff with buzzword compliant technology (and lasers).

Ant Jones

Ant Jones is VP of Engineering at Oxford Nanopore, responsible for bringing all of Nanopore?s products from concept to production; this covers Industrial design, mechanical design, electronic design, production process and equipment development and validation. Ant has 20+ years? experience mainly with-in the medical device industry taking ideas from concept to regulatory approved commercial products.

Ant joined Oxford Nanopore from Lombard Medical where he was head of design developing an AAA endovascular stent graft system which has class III medical device approval worldwide. Previous to this he has designed within: IVD, Orthopeadics, automotive and Plastics industries.

Nirmala Santiapillai

Nirmala joined Oxford Nanopore in 2020 to develop the global services team. Her remit includes leading our customer service, technical and commercial operations functions.

Nirmala initially focused on establishing regionalised customer service to serve local customers in their local time zones and languages. To this end, she onboarded three new leaders who, in turn, have been growing their teams so all are replete with the right talent, capabilities, performance metrics and training.

Nirmala works in partnership with others in senior management to ensure customer service is optimised from the root. She has also created successful business process outsourcing for some straightforward deliverables so her Oxford Nanopore teams can focus on more challenging customer issues.

Nirmala is now focused on continuing to collaborate to deliver positive customer experience, technical support for customers to drive optimal utilisation and scaling commercial operations through increased automation.

Nirmala has worked in the healthcare field since 1989 and has programme leadership and business improvement experience gained from corporate and start-up environments. Prior to joining Oxford Nanopore she worked for General Electric where she held marketing, commercial and customer experience roles within the healthcare business.

Nirmala has a PhD in Neurochemistry from the University of Cambridge and a BSc in Biochemistry from Imperial College London.

Oxford Nanopore Technologies Logo

PRODUCTS

APPLICATIONS STORE RESOURCES SUPPORT

ABOUT

Contact Login / Register WHICH AREA OF CONTENT WOULD YOU LIKE TO SEARCH? ALL What would you like to search for?

HOME/ABOUT US/ Executive team About Oxford Nanopore About us Executive team Board members For partners Company history Media resources Sustainability EXECUTIVE TEAM DEPARTMENTAL LEADERS Executive team The Oxford Nanopore executive team has combined experience in the development, manufacture and commercialisation of disruptive technologies including DNA sequencing. This includes a corporate function to support the Company's past and future fundraising activities.

Dr Gordon Sanghera CHIEF EXECUTIVE OFFICER Nick Keher CHIEF FINANCIAL OFFICER Dr Spike Willcocks CHIEF STRATEGY OFFICER Clive Brown CHIEF TECHNOLOGY, INNOVATION AND PRODUCT OFFICER John Schoellerman SVP, CORP & BUS DEV Tim Cowper CHIEF OPERATING OFFICER Zoe McDougall GLOBAL HEAD, SVP, CORPORATE AFFAIRS Sarah Lapworth SVP, GLOBAL HUMAN RESOURCES Jordan Herman SVP, GENERAL COUNSEL

Departmental leaders Rosemary Sinclair Dokos MBA SVP, PRODUCT & PROGRAMME MANAGEMENT Emma Stanton SVP, CLINICAL AND HEAD OF OND Roger Pettett VP, INFORMATICS Lakmal Jayasinghe SVP, R&D BIOLOGICS Dr James Clarke VP, PLATFORM TECHNOLOGY Kathleen Barnes SVP POPULATION HEALTH & PRECISION MEDICINE Stuart Reid VP, DEVELOPMENT Ant Jones VP, ENGINEERING Andy Davies VP, GLOBAL IT & CUSTOMER SOLUTIONS Nirmala Santiapillai VP, COMMERCIAL OPERATIONS Louisa Ludbrook VP, COMMERCIAL MARKET DEVELOPMENT Richard Compton SVP, SALES AND COMMERCIAL OPERATIONS Martyn Andrews VP, INTELLECTUAL PROPERTY Phil Watkins VP, FINANCE Rhodri Davies VP, OPERATIONS Jeremy Bryar VP, MANUFACTURING Alvaro Correia VP, GLOBAL SUPPLY CHAIN Sara Agee Le VP OF GLOBAL MARKETING Hannah Coote SENIOR DIRECTOR, ASSOCIATE GENERAL COUNSEL Chris Brown VP, STRATEGIC PROGRAMMES Kristen Stoops VP, BUSINESS DEVELOPMENT Howard Orman VP, TECH TRANSFER, QUALITY & REGULATORY

中文 日本語 English GETTING STARTED Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners Japanese dealers NANOPORE TECHNOLOGY Subscribe to Nanopore updates Resources and publications What is the Nanopore Community ABOUT OXFORD NANOPORE News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information CONTACT US Oxford, UK Harwell, UK New York (NY), USA Lexington (MA), USA San Francisco (CA), USA Shanghai, China Tokyo, Japan Singapore, Singapore Oxford Nanopore Technologies

Oxford Nanopore Technologies ISO 27001 Oxford Nanopore TechnologiesISO 9001 Oxford Nanopore Technologies BSI Mark of trust Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility © 2008 - 2024 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.

Martyn Andrews

Martyn is a highly experienced patent attorney having worked mostly for US startup companies in medical diagnostic field. He is Head of IP at ONT. Martyn’s technical background is in academic Chemistry/Electrochemistry BSc/Msc, and he has additional R&D Bioelectrochemistry experience

Phil Watkins

Phil joined Oxford Nanopore in 2020 having consulted for the Company since 2018.

He now heads our finance function, overseeing the department and our financial and management reporting.

Throughout the Company’s fundraising in 2019 and 2020, Phil led the due diligence process liaising with potential investors and managing their advisors. Since joining full time, Phil led a major restructuring of the finance team, boosting both the size of the team and the experience within it. He will continue to oversee the preparation of accurate and timely financial information so senior leadership can make management decisions based on reliable data.

Phil has significant corporate finance experience across acquisitions, disposals and joint ventures, as well as broad commercial experience working with both the private and public sectors. Prior to joining Oxford Nanopore, he was both Managing and Finance Director of GEO Group Inc’s UK subsidiary, successfully winning a number of high profile outsourcing contracts. He has also held a number of senior group finance roles at Jarvis plc, including M&A Director, and spent three years as Finance Director for a number of start-up environmental tech companies.

Phil started his career at Ernst & Young and has a BSc in Agriculture from the University of Reading.

Rhodri Davies

Rhodri joined Oxford Nanopore in 2011 as Director of Chip Production. Since 2016 he has led the Production group with responsibility for managing our technology transfer, manufacturing and quality functions and ensuring they evolve in line with our strategy.

He also offers support across our research, development and supply chain groups, contributing to solutions and providing subject matter expertise.

Looking forward, Rhodri’s goals will be to continue to collaborate and communicate with colleagues, further streamline business processes, and ensure our world-leading science is commercialised and delivered with a customer-first focus.

Rhodri has been working in microengineering since 1999 and has delivered solutions to a broad range of customers across military and commercial markets. He has three patents and over 12 publications.

He has held leadership roles in material science research, product and process development, technology transfer, manufacturing and performance management. Before joining Oxford Nanopore he was Process Manager within the Sensors & Electronics Group at QinetiQ.

Rhodri has a BSc in Physics from the University of Wales.

Oxford Nanopore Technologies Logo

PRODUCTS

APPLICATIONS STORE RESOURCES SUPPORT

ABOUT

Contact Login / Register WHICH AREA OF CONTENT WOULD YOU LIKE TO SEARCH? ALL What would you like to search for?

HOME/ABOUT US/ Executive team About Oxford Nanopore About us Executive team Board members For partners Company history Media resources Sustainability EXECUTIVE TEAM DEPARTMENTAL LEADERS Executive team The Oxford Nanopore executive team has combined experience in the development, manufacture and commercialisation of disruptive technologies including DNA sequencing. This includes a corporate function to support the Company's past and future fundraising activities.

Dr Gordon Sanghera CHIEF EXECUTIVE OFFICER Nick Keher CHIEF FINANCIAL OFFICER Dr Spike Willcocks CHIEF STRATEGY OFFICER Clive Brown CHIEF TECHNOLOGY, INNOVATION AND PRODUCT OFFICER John Schoellerman SVP, CORP & BUS DEV Tim Cowper CHIEF OPERATING OFFICER Zoe McDougall GLOBAL HEAD, SVP, CORPORATE AFFAIRS Sarah Lapworth SVP, GLOBAL HUMAN RESOURCES Jordan Herman SVP, GENERAL COUNSEL

Departmental leaders Rosemary Sinclair Dokos MBA SVP, PRODUCT & PROGRAMME MANAGEMENT Emma Stanton SVP, CLINICAL AND HEAD OF OND Roger Pettett VP, INFORMATICS Lakmal Jayasinghe SVP, R&D BIOLOGICS Dr James Clarke VP, PLATFORM TECHNOLOGY Kathleen Barnes SVP POPULATION HEALTH & PRECISION MEDICINE Stuart Reid VP, DEVELOPMENT Ant Jones VP, ENGINEERING Andy Davies VP, GLOBAL IT & CUSTOMER SOLUTIONS Nirmala Santiapillai VP, COMMERCIAL OPERATIONS Louisa Ludbrook VP, COMMERCIAL MARKET DEVELOPMENT Richard Compton SVP, SALES AND COMMERCIAL OPERATIONS Martyn Andrews VP, INTELLECTUAL PROPERTY Phil Watkins VP, FINANCE Rhodri Davies VP, OPERATIONS Jeremy Bryar VP, MANUFACTURING Alvaro Correia VP, GLOBAL SUPPLY CHAIN Sara Agee Le VP OF GLOBAL MARKETING Hannah Coote SENIOR DIRECTOR, ASSOCIATE GENERAL COUNSEL

Jeremy Bryar

Jerry joined Oxford Nanopore in 2014 as our Director of Continuous Improvement. His initial deliverables were to set up our first manufacturing operation and develop a blueprint for scaling it.

Jerry is now Plant Director, and has driven the design, build and fit out of our new world class manufacturing, warehousing and logistics site, the MinION Building, in record time.

Jerry is now responsible for all aspects of our manufacturing operation. He leads an 80-strong team and is also currently planning future expansion projects in the UK and developing a regional presence for manufacturing overseas.

Jerry is looking forward to being part of the future of sequencing technology, the growth and impact of our Diagnostic technology function and playing his part in bringing products to market which have so many applications and opportunities to do good around the world.

Prior to joining Oxford Nanopore Jerry was a Master Black Belt at Abbott Laboratories, and supported the deployment of Lean Six Sigma continuous improvement methodologies in Europe. In his 40 years career he has also worked on the manufacture of medical devices, nutritional products and biotechnology.

Alvaro Correia

Alvaro joined Oxford Nanopore in 2017 and is now heads up our global supply chain team. Alvaro has formalised the supply chain function through upgrading systems and implementing new processes. He has developed a team with broad skills across sourcing and supplier management, warehousing, inventory management, production, demand planning and distribution.

Leading the supply chain function in a disruptive organisation, Alvaro’s goal is to strengthen the business by providing best- in-class supply chain operations. This delivers competitive advantage through firm foundations and systems, solid processes and well trained teams - all primed for targeted growth.

The supply chain’s goal is to operate successfully even in the face of external circumstances. In 2020, this was epitomised by extreme weather and erupting volcanoes to the worldwide pandemic, through which the supply chain team at Oxford Nanopore were able to scale up operations and production volumes.

Alvaro’s experience spans sales, project management, engineering design and production, planning, procurement, inventory and logistics management. Prior to joining Oxford Nanopore he managed the supply chain at Oxford Instruments NanoAnalysis, where he facilitated the relocation of a manufacturing facility and its associated supply chain from the USA to the UK. He’s also worked at Multotec, a German-owned South Africa- based group of manufacturing companies with diversified supply chains.

Alvaro has an MBA from Henley Business School and a Supply Chain Diploma from SAPICS. He also has a BTech in Business Admin, and an HND in Mechanical Engineering, both from the University of Johannesburg.

Oxford Nanopore Technologies Logo

PRODUCTS

APPLICATIONS STORE RESOURCES SUPPORT

ABOUT

Contact Login / Register WHICH AREA OF CONTENT WOULD YOU LIKE TO SEARCH? ALL What would you like to search for?

HOME/ABOUT US/ Executive team About Oxford Nanopore About us Executive team Board members For partners Company history Media resources Sustainability EXECUTIVE TEAM DEPARTMENTAL LEADERS Executive team The Oxford Nanopore executive team has combined experience in the development, manufacture and commercialisation of disruptive technologies including DNA sequencing. This includes a corporate function to support the Company's past and future fundraising activities.

Dr Gordon Sanghera CHIEF EXECUTIVE OFFICER Nick Keher CHIEF FINANCIAL OFFICER Dr Spike Willcocks CHIEF STRATEGY OFFICER Clive Brown CHIEF TECHNOLOGY, INNOVATION AND PRODUCT OFFICER John Schoellerman SVP, CORP & BUS DEV Tim Cowper CHIEF OPERATING OFFICER Zoe McDougall GLOBAL HEAD, SVP, CORPORATE AFFAIRS Sarah Lapworth SVP, GLOBAL HUMAN RESOURCES Jordan Herman SVP, GENERAL COUNSEL

Departmental leaders Rosemary Sinclair Dokos MBA SVP, PRODUCT & PROGRAMME MANAGEMENT Emma Stanton SVP, CLINICAL AND HEAD OF OND Roger Pettett VP, INFORMATICS Lakmal Jayasinghe SVP, R&D BIOLOGICS Dr James Clarke VP, PLATFORM TECHNOLOGY Kathleen Barnes SVP POPULATION HEALTH & PRECISION MEDICINE Stuart Reid VP, DEVELOPMENT Ant Jones VP, ENGINEERING Andy Davies VP, GLOBAL IT & CUSTOMER SOLUTIONS Nirmala Santiapillai VP, COMMERCIAL OPERATIONS Louisa Ludbrook VP, COMMERCIAL MARKET DEVELOPMENT Richard Compton SVP, SALES AND COMMERCIAL OPERATIONS Martyn Andrews VP, INTELLECTUAL PROPERTY Phil Watkins VP, FINANCE Rhodri Davies VP, OPERATIONS Jeremy Bryar VP, MANUFACTURING Alvaro Correia VP, GLOBAL SUPPLY CHAIN Sara Agee Le VP OF GLOBAL MARKETING Hannah Coote SENIOR DIRECTOR, ASSOCIATE GENERAL COUNSEL Chris Brown VP, STRATEGIC PROGRAMMES

Sara Agee Le

Sara Agee Le, PhD is VP of Global Marketing at Oxford Nanopore Technologies, having joined in July of 2021 to scale the global marketing team in line with the Company’s growth ambitions.

Sara has more than 15 years of experience growing life science companies, with a strong track record of advancing market leadership and commercialization of emerging life science brands.

Most notably, Sara served as Corporate Marketing and Communications Director for 10x Genomics, a market leader in single cell and spatial genomics. Sara joined 10x Genomics in 2016 at the first launch of the Chromium Single Cell System, and held successive roles as Head of Commercial Marketing before transitioning to lead Corporate Marketing and Communications ahead of the company’s IPO.

In addition to 10x, Sara held marketing leadership roles at Atomwise (VP of Marketing and Communications), Seegene Technologies (establishing US subsidiary in 2015), Bina Technologies (acquired by Roche Sequencing in 2014), and Advanced Cell Diagnostics (acquired by BioTechne in 2016 and launch of RNAscope brand).

Prior to working in the life science industry, Sara led the first K-8 curriculum initiative for ScienceBuddies, an award-winning non-profit organization furthering STEM literacy amongst K-12 students, parents, and teachers. She received her PhD in Molecular and Cell Biology from the University of California Berkeley in 2004, and her BS in Biological Sciences from the University of Denver in 1997, graduating Magna Cum Laude.

Hannah Coote

Hannah is Senior Director, Associate General Counsel. She joined ONT in 2020, having followed our journey for several years, and was attracted by our exciting, disruptive technology and the opportunity to work for a world-changing business.

Hannah specialises in corporate law and advises ONT on a range of matters including corporate transactions, corporate governance, compliance and commercial matters.

As part of an expanding legal team, Hannah is collaborating with her legal colleagues around the world to further establish the legal team as an innovative and pragmatic partner within the business.

Hannah joined ONT from FTSE 250 intellectual property commercialisation company IP Group plc, where she provided legal services to the group and its portfolio of companies. Hannah was also company secretary for AIM-listed AI company Mirriad Advertising plc.

Hannah trained and qualified at US law firm Orrick, Herrington & Sutcliffe, where she specialised in venture capital and M&A transactions with a focus on the technology sector.

Chris Brown

Chris joined Oxford Nanopore Technologies in October 2020 from Sharp Corp, where he led the setup of Sharp Life Sciences.

Since joining Oxford Nanopore, Chris has guided the setup of subsidiary conpany structures.

He will continue to lead and advise on key strategic projects and programmes for the Company, particularly looking to engage with markets beyond Life Science research tools, including potential clinical markets.

Kristen Stoops

Kristen has 20 years’ experience in industry where biology meets informatics. including a seven-year tenure with software firm Spotfire (now part of Tibco), where she directed all aspects of its commercial partner program in life sciences.

From 2006 to 2008, Kristen served as director of informatics business development at Helicos BioSciences, and following that she served as senior director of strategic marketing and new business development at Merck's Rosetta Biosoftware business unit. She also cofounded Neotron, a developer of nuclear detection technologies, in 2009. She holds an MA and a BA in physics